Johannes Hov awarded prestigious ERC research grant to study cause and treatments for PSC

NoPSC group leader Johannes Hov has received a Starting Grant of 1.5 million EUR from the European Research Council (ERC) to investigate the importance of intestinal bacteria in disease and determine whether exiting drug targeting gut bacteria can be used to treat primary sclerosing cholangitis (PSC) .

For more information, please see:





Page visits: 185